Physician profile
David Fry
NPI 1528600749
$981.62
in general payments reported to CMS, 2019-2025
14 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $100 · 2023: $169 · 2024: $94.78 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $207.28 | 2021 | |
| Cranial Technologies, INC | $148.69 | 2021-2025 | Doc Band |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Tris Pharma INC | $111.92 | 2021-2022 | |
| Glaxosmithkline, LLC. | $75.40 | 2021-2024 | Bexsero |
| Pfizer INC. | $72.03 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $71.07 | 2021-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Sanofi Pasteur INC. | $67.41 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $22.09 | 2025 | |
| Janssen Biotech, INC. | $18.99 | 2025 | Tremfya |
| Alk-Abello, INC | $17.93 | 2025 | Neffy |
| Novo Nordisk INC | $16.62 | 2023 | Wegovy |
| Organon LLC | $13.84 | 2025 | |
| Aytu Biopharma, INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.